logo

DOC

Healthpeak·NYSE
--
--(--)
--
--(--)
0.16 / 10
Underperform

Fundamental analysis reveals poor positioning (0.2/10). Favorable aspects: Cash-UP and Diluted earnings per share (YoY growth rate %), offset by weaknesses in Net income-Revenue and Asset-MV. Composite outlook: challenging.

Fundamental(0.16)SentimentTechnical

Analysis Checks(2/10)

Revenue-MV
Value-0.43
Score0/3
Weight109.68%
1M Return-5.91%
Net assets per share (growth rate compared to beginning of year %)
Value-10.16
Score1/3
Weight36.28%
1M Return-1.71%
Net income-Revenue
Value0.31
Score0/3
Weight15.07%
1M Return-0.48%
PB-ROE
Value-0.49
Score0/3
Weight72.43%
1M Return-3.90%
Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)
Value-10.73
Score0/3
Weight44.00%
1M Return-1.98%
Income tax / Total profit (%)
Value3.27
Score0/3
Weight12.60%
1M Return-0.52%
Cash-UP
Value-0.21
Score2/3
Weight-238.29%
1M Return5.13%
Diluted earnings per share (YoY growth rate %)
Value-72.22
Score3/3
Weight-108.78%
1M Return3.43%
Asset-MV
Value0.58
Score0/3
Weight101.22%
1M Return-5.45%
Cash-MV
Value0.16
Score1/3
Weight55.80%
1M Return-2.00%
Is DOC undervalued or overvalued?
  • DOC scores 0.16/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.81% ROE, 3.58% net margin, 166.09 P/E ratio, 1.41 P/B ratio, and -72.22% earnings growth, these metrics solidify its Underperform investment rating.